B. Strobl

2.4k citations

24 papers · 808 indexed · h-index 12

Impact in

Oncology top 5%
- Cancer survivorship and care
- Cancer Cells and Metastasis
- Bone health and treatments
- Cancer Diagnosis and Treatment
Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics

Papers in ⓘ

Cancer Research 10
- Breast Cancer Treatment Studies 10
Oncology 17
- Cancer Cells and Metastasis 4
- Cancer Treatment and Pharmacology 3
- Bone health and treatments 3
- HER2/EGFR in Cancer Research 2

Co-authors: Wolfgang Janni (9 shared papers)Brigitte Rack (13 shared papers)D. Rjosk (13 shared papers)Christian Schindlbeck (10 shared papers)Harald Sommer (7 shared papers)H. Sommer (5 shared papers)Kristin Härtl (2 shared papers)Klaus Friese (5 shared papers)
Journals: Cancer (3 papers)Journal of Clinical Oncology (3 papers)Acta Obstetricia Et Gynecologica Scandinavica (2 papers)European Journal of Cancer (1 paper)The Breast (1 paper)
Partner nations: Germany Austria

In The Last Decade

B. Strobl

23 papers receiving 770 citations

Peers

Countries citing papers authored by B. Strobl

Since Specialization

Citations

This map shows the geographic impact of B. Strobl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Strobl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Strobl more than expected).

Fields of papers citing papers by B. Strobl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Strobl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Strobl. The network helps show where B. Strobl may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Strobl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Strobl Line = papers co-authored together B. Strobl links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients Annals of Oncology ·Kristin Härtl, Wolfgang Janni, R Kästner, H. Sommer, B. Strobl, Brigitte Rack, M. Stauber	2003	170
2	The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence Cancer ·Wolfgang Janni, Brigitte Rack, Christian Schindlbeck, B. Strobl, D. Rjosk, Stephan Braun, Harald Sommer, Klaus Pantel, Bernd Gerber, Klaus Friese	2005	124
3	Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer. PubMed ·Brigitte Rack, Julia Jückstöck, Eva-Maria Genss, A. Schoberth, Christian Schindlbeck, B. Strobl, M Heinrigs, Gerhard Rammel, Thomas Zwingers, Harald Sommer, Klaus Friese, Wolfgang Janni	2010	99
4	Quality of Life Influenced by Primary Surgical Treatment for Stage I-III Breast Cancer?Long-Term Follow-Up of a Matched-Pair Analysis Annals of Surgical Oncology ·W. Janni, D. Rjosk, Th. Dimpfl, Kristin Haertl, B. Strobl, F. Hepp, Alexander Hanke, F. Bergauer, H Sommer	2001	96
5	The prognostic impact of a prolonged second stage of labor on maternal and fetal outcome Acta Obstetricia Et Gynecologica Scandinavica ·Wolfgang Janni, B Schießl, Ursula Peschers, Sandra Huber, B. Strobl, Peer Hantschmann, Natalie Uhlmann, T. Dimpfl, Gerhard Rammel, Franz Kainer	2002	85
6	The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence Cancer ·Wolfgang Janni, F. Hepp, D. Rjosk, Christina Kentenich, B. Strobl, Christian Schindlbeck, Peer Hantschmann, Harald Sommer, Klaus Pantel, Stephan Braun	2001	62
7	Patients with Recurrent Breast Cancer: Does the Primary Axillary Lymph node Status Predict more Aggressive Tumor Progression? Breast Cancer Research and Treatment ·Brigitte Rack, Wolfgang Janni, Bernd Gerber, B. Strobl, Christian Schindlbeck, E. Klanner, Gerhard Rammel, Harald Sommer, T. Dimpfl, Klaus Friese	2003	32
8	Quality of life influenced by primary surgical treatment for stage I–III breast cancer - long-term follow-up of a matched-pair analysis European Journal of Cancer ·W Janni, Kristin Härtl, B. Strobl, D. Rjosk, B Rack, Alexander Hanke, Th. Dimpfl, H. Sommer	2001	26
9	Zoledronsäure bei persistierenden isolierten Tumorzellen im Knochenmark bei Mammakarzinom DMW - Deutsche Medizinische Wochenschrift ·Brigitte Rack, Christian Schindlbeck, B. Strobl, H. Sommer, K Friese, W Janni	2008	21
10	Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus Cancer ·Wolfgang Janni, F. Hepp, B. Strobl, Brigitte Rack, D. Rjosk, Christina Kentenich, Christian Schindlbeck, Peer Hantschmann, Klaus Pantel, Harald Sommer, Stephan Braun	2003	21
11	Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases Journal of Cancer Research and Clinical Oncology ·Wolfgang Janni, Brigitte Rack, Harald Sommer, Maren Schmidt, B. Strobl, D. Rjosk, E. Klanner, W. Thieleke, Bernd Gerber, Klaus Friese, T. Dimpfl	2003	20
12	Effect of zoledronate on persisting isolated tumor cells (ITC) in the bone marrow (BM) of patients without recurrence of early breast cancer Journal of Clinical Oncology ·Brigitte Rack, W Janni, A. Schoberth, Christian Schindlbeck, B. Strobl, Thomas Blankenstein, D. Rjosk, M Heinrigs, H Sommer, K Friese	2004	13
13	The prognostic impact of a prolonged second stage of labor on maternal and fetal outcome Acta Obstetricia Et Gynecologica Scandinavica ·Wolfgang Janni, B Schießl, Ursula Peschers, Sandra Huber, B. Strobl, Peer Hantschmann, Natalie Uhlmann, T. Dimpfl, Gerhard Rammel, Franz Kainer	2002	8
14	Paravasation with Cyclophosphamide – Case Report of Tissue Necrosis in a Patient with Primary Breast Cancer Oncology Research and Treatment ·J Jueckstock, Ioannis Mylonas, B. Strobl, F Willgeroth, Harald Sommer, Klaus Friese	2007	7
15	Chemotherapieassoziierte Myelosuppression in der gynäkologischen Onkologie Gyn�kologisch-geburtshilfliche Rundschau ·Wolfgang Janni, D. Rjosk, B. Strobl, F. Bergauer, F. Linka, T. Dimpfl, Christian Schindlbeck, Brigitte Rack, Rolf Kaestner, H. Sommer	2001	5
16	Phase III study evaluating the role of docetaxel in the adjuvant therapy of breast cancer patients with extensive lymph node involvement (4 nodes+) — ADEBAR study The Breast ·B Rack, W Janni, Nadia Harbeck, I. Zemzoun, B. Strobl, E. Klanner, J. De Waal, C Schindlbeck, Marion Kiechle, H. Sommer	2003	4
17	Association of persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients with risk for relapse Journal of Clinical Oncology ·W Janni, B Rack, C Schindlbeck, B. Strobl, D. Rjosk, Susanne Braun, H Sommer, Klaus Pantel, B. Gerber, K Friese	2004	4
18	Fortschritte in der Früherkennung des Mammakarzinoms in den Jahren 1981 - 1990 DMW - Deutsche Medizinische Wochenschrift ·Wolfgang Janni, H. Sommer, B. Strobl, Brigitte Rack, E. Klanner, Peer Hantschmann, Gerhard Rammel, Gundel Harms, T. Dimpfl	2003	2
19	Der Einfluss des Hämoglobinwertes auf die hämatogene Tumorzelldisseminierung zum Zeitpunkt der Primärdiagnose des Mammakarzinoms DMW - Deutsche Medizinische Wochenschrift ·W Janni, B. Strobl, B Rack, D. Rjosk, Christian Schindlbeck, Peer Hantschmann, C.R.M. Kentenich, W Sigg, M Zerzer, H Sommer	2002	2
20	Whole body hyperthermia combined with carboplatin/ paclitaxel in patients with ovarian carcinoma –Phase-II-study Journal of Clinical Oncology ·B. Strobl, D. Rjosk, W Janni, Brigitte Rack, E. Klanner, M Heinrigs, H Sommer	2004	2

About B. Strobl

B. Strobl is a scholar working on Cancer Research, Oncology, Obstetrics and Gynecology, Pathology and Forensic Medicine and Emergency Medicine, having authored 24 papers that have together received 808 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (5 papers), Cancer Cells and Metastasis (4 papers), Cancer Treatment and Pharmacology (3 papers), Bone health and treatments (3 papers), Hematological disorders and diagnostics (2 papers), HER2/EGFR in Cancer Research (2 papers) and Maternal and Perinatal Health Interventions (2 papers). The work is most often cited by research in Oncology (589 citations), Cancer Research (273 citations), Obstetrics and Gynecology (76 citations), Pulmonary and Respiratory Medicine (186 citations) and Pediatrics, Perinatology and Child Health (103 citations). B. Strobl has collaborated with scholars based in Germany and Austria. Frequent co-authors include Wolfgang Janni, Brigitte Rack, D. Rjosk, Christian Schindlbeck, Harald Sommer, H. Sommer, Kristin Härtl, Klaus Friese, M. Stauber and R Kästner. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Acta Obstetricia Et Gynecologica Scandinavica, European Journal of Cancer and The Breast.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact